GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » Net Interest Income

We Can Medicines Co (ROCO:6929) Net Interest Income : NT$-26 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is We Can Medicines Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. We Can Medicines Co's net interest income for the three months ended in Dec. 2024 was NT$-6 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-26 Mil.

We Can Medicines Co Net Interest Income Historical Data

The historical data trend for We Can Medicines Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

We Can Medicines Co Net Interest Income Chart

We Can Medicines Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
-13.20 -14.38 -18.85 -22.84 -26.18

We Can Medicines Co Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.40 -7.61 -6.24 -6.42 -5.91

We Can Medicines Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

We Can Medicines Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

We Can Medicines Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » Net Interest Income
Comparable Companies
ROCO:2756 ROCO:6886 ROCO:6578 ROCO:4109 ROCO:1294 TPE:1220 ROCO:6968 ROCO:6963 TPE:1233 ROCO:8905 XSWX:NESN XPAR:BN KHC GIS SHSE:603288 K NSE:NESTLEIND SHSE:600887 SZSE:300999 MKC
Traded in Other Exchanges
N/A
Address
Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN
Website
http://www.yourchance.com.tw
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.

We Can Medicines Co Headlines

No Headlines